Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-24 4:51 PM View:  | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 368 | $7.02 | $2,583.36 | (1%) 27.26K to 26.89K | |
| 16-May-24 7:00 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 368 | $8.36 | $3,076.48 | (1%) 27.63K to 27.26K | |
| 16-Feb-24 5:12 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 434 | $3.40 | $1,475.60 | (2%) 28.06K to 27.63K | |
| 16-Nov-23 7:42 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 1,470 | $5.08 | $7,467.60 | (5%) 29.53K to 28.06K | |
| 16-Nov-22 7:13 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant | 20,030 | -- | -- | 100% 0 to 20.03K |